MONOGRAPH LIBRARY
Losartan (Cozaar, first FDA-approved 1995) is the prototype angiotensin II receptor blocker. It shares the class-level mechanism (selective AT1 receptor blockade), core indications (hypertension, diabetic nephropathy, heart failure, cardiovascular…
Pinealon (Glu-Asp-Arg) is a synthetic tripeptide developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. It is part of the broader Khavinson 'short peptide' bioregulator program, which has…
NMN raises NAD+ levels in humans with solid mechanistic rationale and early clinical data. Updated September 2025: FDA confirmed NMN lawful as a dietary supplement, reversing a 2022 exclusion.
Rapamycin (sirolimus) and metformin are the two off-label drugs most often discussed in the longevity optimization conversation. Both have substantial preclinical evidence for healthspan or lifespan benefit, both have been the subject of ongoing…
Bug report, content request, or general comment — we read everything.